San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story and see what’s trending.

Recursion founders gin fortunes as IPO backers shower $436M on one of the biggest boasts in AI — based on some very small deals
Bioregnum Opinion Column by John Carroll In the AI drug development world, boasting often comes with the territory. Yet few can rival Recursion when it comes to claiming the lead role in what company execs like to call the industrialization of drug development, with promises of… Click here to view original post… […]